Periodontal Therapeutics Market Size, Share, Growth, Trends, Consumption, Production, Revenue and Forecast 2022 - 2030

The global periodontal therapeutics market size was valued at US$ 0.64 billion in 2021 and expected to reach US$ 1.38 billion by 2030 with a CAGR of 8.9% from 2022 to 2030.

Rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market

Local Antibiotics Segment to Account for Significant Market Share

• Surge in awareness about oral health primarily driven by national and community policies regarding effective control on diet and nutrition risk factors for oral diseases such as periodontal and dental disease, and development of novel products for the treatment of periodontal diseases are expected to provide fillip for antibiotic based treatment options. Companies can also focus on introducing locally applied antibiotics in countries with sizeable population affected with periodontal diseases in order to capitalize on the large unmet needs in these countries.
• The growth of the segment can be attributed to the advantages offered by locally applied antibiotics over systemic antibiotics. Local route of drug delivery provides 100-fold higher concentrations of an antimicrobial agent in the subgingival sites in comparison to a systemic drug regimen, which, in turn, reduces the total patient dose by more than 400-fold
• Local antibiotics also help in reducing the potential problems associated with the use of systemic antibiotic drugs and can negate the development of drug resistant microbial population in non-oral body sites
• Additionally, focus of pharmaceutical companies on the development of improved local antibiotics is expected to further boost the demand for these products

Prominent Regions

• North America held the largest share of the global periodontal therapeutics market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period, driven by presence of key players, high adoption of technological advancements, and highly structured health care industry.
• Increase in clinical trials, product launches & approvals, and rise in investment by key players are projected to propel the periodontal therapeutics market in North America
• The U.S. is anticipated to dominate the periodontal therapeutics market in the region during the forecast period. People in the U.S. are living longer and keeping more of their teeth in old age. As the elderly population increases, its oral health needs and ability to access care are gaining more attention. An estimated 70% of seniors lack or have limited dental insurance, and fewer than half access dental care each year.
• The health care delivery system is changing rapidly with the implementation of the Affordable Care Act. Millions of previously uninsured low-income adults gained coverage under the Affordable Care Act’s Medicaid expansions.
• The percentage of people covered by any type of health insurance increased by 1.3 percentage points to 90.9% in 2015, up from 89.6% in 2014. In 2015, private health insurance coverage continued to be more prevalent than public coverage, at 67.2% and 37.1%, respectively.

Key Players

• Key players in the global periodontal therapeutics market focus on strengthening their positions in the global market 
• Players are collaborating with other companies, actively conducting research studies, participating in mergers & acquisitions, and increasing product approvals and launches to secure and strengthen their positions in the global periodontal therapeutics market.
• In February 2017, Oral Science announced its decision to launch Fluorimax, a next-generation of fluoride varnishes intended to be used for the treatment of dental caries
• Major players operating in the global periodontal therapeutics market include Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, and Kaken Pharmaceutical Co., Ltd.

The global periodontal therapeutics market has been segmented as follows:

By Product

• • Systemic Antibiotics
    • Arestin
    • Periochip
    • Atridox
    • Others
  • Local Antibiotics
    • Arestin
    • Atridox
    • PerioChip
    • Others

By Distribution Channel

• • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • E-Commerce

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

A new study on the global periodontal therapeutics market has been published by Vision Research Reports. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global periodontal therapeutics market. The study offers valuable information about the global periodontal therapeutics market to illustrate how the market would grow during the forecast period 2020-2027. The report provides the value and volume of the global periodontal therapeutics market for the period 2020–2027, considering 2020 as the base year and 2027 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.

Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global periodontal therapeutics market during the forecast period.

An extensive analysis on business strategies of leading market players is also featured in study on the global periodontal therapeutics market. This can help readers understand principal factors to foresee growth in the global periodontal therapeutics market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.

The report also delves into the competition landscape of the global periodontal therapeutics market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.

Key Questions Answered in Periodontal therapeutics Market Study

- What are the key factors influencing the periodontal therapeutics market in each region?

- What will be the CAGR of the global periodontal therapeutics market between 2016 and 2027?

- What is the future scope and changing trends in technologies in the global periodontal therapeutics market?

- Which factors will impede the growth of the global periodontal therapeutics market during the forecast period?

- Which are the leading companies in the global periodontal therapeutics market?

- Which region is set to expand at the fastest CAGR during the forecast period?

- What is the volume (Units) of different periodontal therapeutics across all regions during the forecast period?

- Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?

Research Methodology

A unique research methodology has been utilized by Vision Research Reports to conduct a comprehensive research on the growth of the global periodontal therapeutics market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global periodontal therapeutics market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from periodontal therapeutics industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making Vision Research Reports estimates on the future prospects of the global market more reliable and accurate.